SPRAVATO Patient Resources
We support our patients every step of the way with the following materials and tools:
What is Spravato Nasal Spray
Spravato is an FDA-approved nasal spray containing esketamine, a compound related to ketamine, specifically designed for individuals with treatment-resistant depression and major depressive disorder.
We are pleased to offer this innovative treatment, which is covered by most insurance plans, including commercial insurances and selected Medicaid plans.
Important Safety Information About SPRAVATO
At MindBodyPinnacle Health, we ensure all patients receive comprehensive safety guidance before starting treatment. Below are key safety considerations:
-
Sedation, dissociation, and respiratory depression: May cause dizziness, sedation, disconnection from self (dissociation), and breathing problems. You will be monitored for at least 2 hours post-dose.
-
Abuse and misuse potential: Your provider will assess substance use history before and during treatment.
-
REMS Program access only: SPRAVATO is only available through certified REMS clinics like ours.
-
Suicidal thoughts and behaviors: Particularly in patients under 24. Monitoring for mood changes is essential.
How Spravato Nasal Spray Works
At MindBodyPinnacle Health, we prioritize thorough care. After administering Spravato, we monitor patients for a minimum of two hours for safety and comfort. This period also facilitates ketamine-assisted psychotherapy, which may occur during the latter part of observation or the next day. These sessions are crucial for integrating treatment experiences into the broader therapeutic process, often resulting in major breakthroughs and improved healing from trauma.
Who Qualifies for Treatment?
You may qualify if you:
-
Have not responded adequately to two or more oral antidepressants
-
Are 18 years or older
-
Can receive treatment in a REMS-certified clinic
-
Do not have contraindications like uncontrolled hypertension
What to Expect During Treatment
-
Consultation & Evaluation: Includes review of treatment history and assessment for Spravato® eligibility.
-
Self-Administration: Patients administer Spravato® via nasal spray under supervision.
-
Monitoring Period: Remain at our clinic for 2 hours for vital sign and side effect monitoring.
-
Treatment Schedule:
-
Weeks 1-4: 2 treatments/week
-
Weeks 5-8: 1 treatment/week
-
Week 9+: Maintenance phase, based on response
-
Common Side Effects
-
Dizziness, nausea, headache, blood pressure increase
-
Dissociation, sleepiness, anxiety
-
Typically resolve same day
The Synergy of Therapy and Spravato:
At MindBodyPinnacle Health, we embrace the synergy between Spravato treatment and therapy to enhance overall mental health. This combined approach significantly boosts neural network flexibility, improving emotional engagement and the mind-body connection. It offers new perspectives on traumatic memories, easing anxiety and deepening understanding. By integrating rapid symptom relief with targeted therapy, this method fosters profound insights and effective change strategies, supporting personal growth within a therapeutic framework. Our commitment to combining medication with psychotherapy aims to provide holistic, transformative care.
Starting Your Journey with Spravato at MindBodyPinnacle Health
Your journey to ketamine-assisted psychotherapy starts with a detailed 60-minute intake session, available both in-person and online, where we discuss your mental health goals, lifestyle, and medical history to create a customized treatment plan. We work closely with your insurance to handle pre-authorizations and minimize your costs, informing you about all financial options. While IV ketamine is often not covered, Spravato™ is more likely to be insurance-eligible and comes with a rebate program that could reduce costs to as low as $10 per visit.